Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

ASPAVELI 1080 mg solution for infusion {equilateral_black_triangle}

Active Ingredient:
pegcetacoplan
Company:  
Swedish Orphan Biovitrum Ltd See contact details
ATC code: 
L04AJ03
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Aspaveli - Guide for Healthcare Professional

{healthcare_pro_orange} For Healthcare Professionals

Guide for Healthcare Professionals to aid with early detection, careful monitoring, and prompt

management of important safety concerns when prescribing pegcetacoplan.

{pdf_link}

Aspaveli - Guide for Patient and Caregivers

This guide contains important information and safety considerations for pegcetacoplan, including the risk of serious infections (including meningitis) and guidance on self administration.

{pdf_link}

Aspaveli - Patient Card

Important information for patients taking Aspaveli (pegcetacoplan)

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Swedish Orphan Biovitrum Ltd
Company image
Address
Suite 2, Riverside 3, Granta Park, Great Abington,, Cambridgeshire, CB21 6AD, UK
Telephone
+44 (0) 1223 891854
Medical Information Direct Line
+44 (0) 800 111 4754
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0) 800 111 4754
WWW
http://www.sobi.com